1. MicroRNA and cyclooxygenase-2 in breast cancer
   Wanjun Li et al, 2021, Clinica Chimica Acta CrossRef
2. Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
   Khadijeh Barzaman et al, 2022, Cancer Cell International CrossRef
3. Determining the expression levels of circulating tumour cell markers in canine mammary tumours
   Zeynep Günay Uçmak et al, 2021, Acta Veterinaria Brno CrossRef
4. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis
   Peiwen Ding et al, 2023, Frontiers in Oncology CrossRef
5. Breast cancer stem cells and their role in tumor microenvironment
   Manzoor Ahmad Mir et al, 2022, Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies CrossRef
6. COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma
   Marco Aurélio Petroni Montezuma et al, 2018, Pathology - Research and Practice CrossRef
7. Comparative stemness and differentiation of luminal and basal breast cancer stem cell type under glutamine‐deprivation
   Heena Jariyal et al, 2021, Journal of Cell Communication and Signaling CrossRef
8. Identification of ZG16B as a prognostic biomarker in breast cancer
   Haotian Lu et al, 2020, Open Medicine CrossRef
9. Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition
   Heena Jariyal et al, 2020, International Journal of Biological Macromolecules CrossRef
10. Cyclooxygenase 2 Promotes Proliferation and Invasion in Ovarian Cancer Cells via the PGE2/NF-κB Pathway
    Xiao Zhang et al, 2019, Cell Transplantation CrossRef
11. Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models
    Nino Giunashvili et al, 2024, Molecular Oncology CrossRef